Metaproteomic analysis of human gut microbiome in digestive and metabolic diseases

被引:5
|
作者
Pan, Sheng [1 ]
Chen, Ru [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Div Gastroenterol & Hepatol, Houston, TX 77030 USA
来源
基金
美国国家卫生研究院;
关键词
TOF MASS-SPECTROMETRY; MALDI; IDENTIFICATION; PERSPECTIVES; ASSOCIATION; BACTERIA; CATALOG; HEALTH; HOST;
D O I
10.1016/bs.acc.2019.12.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Metaproteomics, as a subfield of proteomics, has quickly emerged as a pivotal tool for global characterization of a microbiome system at a functional level. It has been increasingly applied in studying human digestive and metabolic diseases, and provides information-rich data to identify the dysbiosis of human gut microbiome related to healthy or disease states to elucidate the molecular events underlying host-microbiota interplays. While significant technical challenges still exist, this emerging technology has been demonstrated to provide essential information in interrogating functional changes in the human gut microbiome, complementary to metagenomics and metatranscriptomics. This chapter overviews the overall metaproteomic work flow and its recent applications in studying human gut microbiome relevant to digestive and metabolic diseases.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Gut microbiome and metabolic diseases
    Shinji Fukuda
    Hiroshi Ohno
    [J]. Seminars in Immunopathology, 2014, 36 : 103 - 114
  • [2] Gut microbiome and metabolic diseases
    Fukuda, Shinji
    Ohno, Hiroshi
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2014, 36 (01) : 103 - 114
  • [3] Metaproteomic and Metabolomic Approaches for Characterizing the Gut Microbiome
    Peters, Danielle L.
    Wang, Wenju
    Zhang, Xu
    Ning, Zhibin
    Mayne, Janice
    Figeys, Daniel
    [J]. PROTEOMICS, 2019, 19 (16)
  • [4] pepFunk: a tool for peptide-centric functional analysis of metaproteomic human gut microbiome studies
    Simopoulos, Caitlin M. A.
    Ning, Zhibin
    Zhang, Xu
    Li, Leyuan
    Walker, Krystal
    Lavallee-Adam, Mathieu
    Figeys, Daniel
    Wren, Jonathan
    [J]. BIOINFORMATICS, 2020, 36 (14) : 4171 - 4179
  • [5] Gut microbiome, dietary lipids and metabolic diseases
    Clavel, Thomas
    [J]. CAHIERS DE NUTRITION ET DE DIETETIQUE, 2019, 54 (06): : 347 - 353
  • [6] Development of an Enhanced Metaproteomic Approach for Deepening the Microbiome Characterization of the Human Infant Gut
    Xiong, Weili
    Giannone, Richard J.
    Morowitz, Michael J.
    Banfield, Jillian F.
    Hettich, Robert L.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2015, 14 (01) : 133 - 141
  • [7] The Human Gut Microbiome in Liver Diseases
    Davis, Brian C.
    Bajaj, Jasmohan S.
    [J]. SEMINARS IN LIVER DISEASE, 2017, 37 (02) : 128 - 140
  • [8] Gut microbiome, endocrine control of gut barrier function and metabolic diseases
    Regnier, Marion
    Van Hul, Matthias
    Knauf, Claude
    Cani, Patrice D.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2021, 248 (02) : R67 - R82
  • [9] The role of the gut microbiome and its metabolites in metabolic diseases
    Wu, Jiayu
    Wang, Kai
    Wang, Xuemei
    Pang, Yanli
    Jiang, Changtao
    [J]. PROTEIN & CELL, 2021, 12 (05) : 360 - 373
  • [10] The role of the gut microbiome and its metabolites in metabolic diseases
    Jiayu Wu
    Kai Wang
    Xuemei Wang
    Yanli Pang
    Changtao Jiang
    [J]. Protein & Cell., 2021, 12 (05) - 373